Status:
RECRUITING
HOBSCOTCH-MS-Efficacy Trial
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Conditions:
Multiple Sclerosis
Cognitive Dysfunction
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
The purpose of this study is to assess the ability of the home-based intervention, HOBSCOTCH-MS to improve the quality of life and cognitive function in Service Members, Veterans and civilians who hav...
Detailed Description
The investigators' hypothesis is that the telehealth delivered evidence-based intervention HOBSCOTCH-MS can be delivered by telehealth to improve QOL and neurocognitive function in PwMS. The innovativ...
Eligibility Criteria
Inclusion
- Inclusion Criteria - MS Participant
- Age 20 - 75 years
- Diagnosis of relapsing or progressive MS
- Education of at least Grade 12 or GED
- Fluent in English
- Subjective cognitive and memory challenges
- Internet access
- Telephone access
- Inclusion Criteria - Caregiver Participant
- 20 years +
- Fluent in English
- Caregiver to a MS Participant
- Participant MS has given permission to Caregiver to enroll with them
- Internet access
- Telephone access
Exclusion
- Exclusion Criteria MS Participant
- Current diagnosed psychiatric disorders (e.g., schizophrenia, bipolar disorder or substance use disorder).
- Other neurological disorder such as epilepsy, brain tumor, severe brain injury or mild to moderate brain injury with a history of 30 or more minutes' loss of consciousness, or other disorder that would confound the focus on MS
- Diagnosed developmental attention, learning, or intellectual disorder; sensory, motor, or physical disability that would prevent engagement with the intervention or render the person unable complete study outcome measures
- Exacerbation of MS symptoms (relapse) or ongoing steroid treatment within three months of study enrollment
- Significant visual impairment precluding reading or writing
- Lack of access to the technical resources (e.g., internet access, telephone) required for participation
- Exclusion Criteria - Caregiver Participant
- Significant visual impairment precluding reading or writing
- No reliable telephone or internet access
Key Trial Info
Start Date :
September 9 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT06951919
Start Date
September 9 2025
End Date
December 1 2028
Last Update
October 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth-Health Lebanon
Lebanon, New Hampshire, United States, 03756